IREN slides as investors refocus on dilution risk tied to expanded $6B share-sale program

IREN Limited (IREN) is down 4.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The pullback appears most consistent with renewed dilution concerns after IREN expanded its at-the-market (ATM) equity sale capacity to up to $6 billion. With the stock already volatile following recent financial updates, traders may be de-risking ahead of potential ongoing share issuance to fund large AI/HPC buildouts.

Details:

IREN filed an updated prospectus supplement that permits offers and sales of up to $6,000,000,000 of ordinary shares through its existing ATM sales agreement, materially increasing potential supply of shares.

The same filing disclosed that the prior ATM program had already been utilized for an aggregate $1.0 billion in gross proceeds (66,707,732 shares sold), reinforcing investor sensitivity to further issuance.

IREN’s latest quarterly results (for the three months ended December 31, 2025) showed total revenue of $184.7 million, a datapoint that has kept attention on funding needs and execution during the business pivot toward AI cloud/HPC.

This could also be a positioning move ahead of upcoming milestones (including data-center and GPU expansion timelines), where delays or incremental capex could heighten financing overhang.

Sources:

IREN Investor Relations, StockTitan, StreetInsider

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$IREN Hedge Fund Activity

We have seen 281 institutional investors add shares of $IREN stock to their portfolio, and 183 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLS FARGO & COMPANY/MN removed 7,444,361 shares (-94.4%) from their portfolio in Q4 2025, for an estimated $281,173,514
JANE STREET GROUP, LLC removed 6,116,167 shares (-52.2%) from their portfolio in Q4 2025, for an estimated $231,007,627
TWO SIGMA INVESTMENTS, LP removed 4,880,720 shares (-94.9%) from their portfolio in Q4 2025, for an estimated $184,344,794
MAREX GROUP PLC added 4,459,032 shares (+36456.8%) to their portfolio in Q4 2025, for an estimated $168,417,638
BNP PARIBAS FINANCIAL MARKETS added 4,201,138 shares (+inf%) to their portfolio in Q4 2025, for an estimated $158,676,982
CLEAR STREET GROUP INC. added 3,629,194 shares (+inf%) to their portfolio in Q4 2025, for an estimated $137,074,657
CITIGROUP INC added 3,450,909 shares (+53.7%) to their portfolio in Q4 2025, for an estimated $130,340,832

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$IREN Congressional Stock Trading

Members of Congress have traded $IREN stock 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $IREN stock by members of Congress over the last 6 months:

REPRESENTATIVE DALE W. STRONG purchased up to $15,000 on 01/28.
REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 2 purchases worth up to $115,000 on 01/20, 12/09 and 1 sale worth up to $100,000 on 12/26.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$IREN Analyst Ratings

Wall Street analysts have issued reports on $IREN in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Underweight" rating on 11/24/2025
Citizens issued a "Market Outperform" rating on 11/19/2025
Canaccord Genuity issued a "Buy" rating on 11/10/2025
Cantor Fitzgerald issued a "Overweight" rating on 11/07/2025
HC Wainwright & Co. issued a "Sell" rating on 11/07/2025

To track analyst ratings and price targets for $IREN, check out Quiver Quantitative's $IREN forecast page.

$IREN Price Targets

Multiple analysts have issued price targets for $IREN recently. We have seen 7 analysts offer price targets for $IREN in the last 6 months, with a median target of $70.0.

Here are some recent targets:

Brett Knoblauch from Cantor Fitzgerald set a target price of $61.0 on 04/09/2026
Joseph Vafi from Canaccord Genuity set a target price of $70.0 on 02/10/2026
Paul Golding from Macquarie set a target price of $70.0 on 02/06/2026
Mike Colonnese from HC Wainwright & Co. set a target price of $80.0 on 01/13/2026
Michael Ng from Goldman Sachs set a target price of $39.0 on 12/18/2025
Reginald Smith from JP Morgan set a target price of $39.0 on 11/24/2025
Greg Miller from Citizens set a target price of $80.0 on 11/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.